These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23103098)

  • 1. (R)- and (S)-4-Amino-3-(trimethylsilyl)methylbutanoic acids ameliorate neuropathic pain without central nervous system-related side effects.
    Muratake H; Ito A; Toda T; Suzuki H; Fukasawa H; Tsuda M; Inoue K; Sugiyama K; Shudo K
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7602-4. PubMed ID: 23103098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary amino acid derivatives: compounds with anticonvulsant and neuropathic pain protection activities.
    King AM; Salomé C; Dinsmore J; Salomé-Grosjean E; De Ryck M; Kaminski R; Valade A; Kohn H
    J Med Chem; 2011 Jul; 54(13):4815-30. PubMed ID: 21639114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide.
    Kaufmann D; Yagen B; Minert A; Tal M; Devor M; Bialer M
    Neuropharmacology; 2008 Mar; 54(4):699-707. PubMed ID: 18201732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary amino acid derivatives: substitution of the 4'-N'-benzylamide site in (R)-N'-benzyl 2-amino-3-methylbutanamide, (R)-N'-benzyl 2-amino-3,3-dimethylbutanamide, and (R)-N'-benzyl 2-amino-3-methoxypropionamide provides potent anticonvulsants with pain-attenuating properties.
    King AM; Salomé C; Salomé-Grosjean E; De Ryck M; Kaminski R; Valade A; Stables JP; Kohn H
    J Med Chem; 2011 Oct; 54(19):6417-31. PubMed ID: 21861463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are antiepileptic drugs used for nonepileptic conditions?
    Bialer M
    Epilepsia; 2012 Dec; 53 Suppl 7():26-33. PubMed ID: 23153207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain.
    Yogeeswari P; Ragavendran JV; Sriram D; Kavya R; Vanitha K; Neelakantan H
    Pharmacology; 2008; 81(1):21-31. PubMed ID: 17785996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach.
    Yogeeswari P; Ragavendran JV; Sriram D; Nageswari Y; Kavya R; Sreevatsan N; Vanitha K; Stables J
    J Med Chem; 2007 May; 50(10):2459-67. PubMed ID: 17451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design, synthesis and antiepileptic activity of 4-(2-acetoxybenzoylamino) butyrate derivatives].
    Liu WH; He D; Yin XQ; Liu Y
    Yao Xue Xue Bao; 2011 Mar; 46(3):299-304. PubMed ID: 21626784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsants in neuropathic pain: rationale and clinical evidence.
    Jensen TS
    Eur J Pain; 2002; 6 Suppl A():61-8. PubMed ID: 11888243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal administration of aqueous pregabalin solution as a potential treatment option for patients with neuropathic pain to avoid central nervous system-mediated side effects.
    Fukasawa H; Muratake H; Nagae M; Sugiyama K; Shudo K
    Biol Pharm Bull; 2014; 37(11):1816-9. PubMed ID: 25212662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silicon-containing GABA derivatives, silagaba compounds, as orally effective agents for treating neuropathic pain without central-nervous-system-related side effects.
    Fukasawa H; Muratake H; Ito A; Suzuki H; Amano Y; Nagae M; Sugiyama K; Shudo K
    ACS Chem Neurosci; 2014 Jul; 5(7):525-32. PubMed ID: 24738473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anticonvulsants for possible use in neuropathic pain.
    Waszkielewicz AM; Gunia A; Słoczyńska K; Marona H
    Curr Med Chem; 2011; 18(28):4344-58. PubMed ID: 21861814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology of neuropathic pain: mode of action of anticonvulsants.
    Dickenson AH; Matthews EA; Suzuki R
    Eur J Pain; 2002; 6 Suppl A():51-60. PubMed ID: 11888242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lacosamide as an alternative in the treatment of post-surgery neuropathic pain in an allergic patient].
    Monge-Márquez ME; Márquez-Rivas J; Mayorga-Buiza MJ; Rivero-Garvía M
    Rev Neurol; 2013 Oct; 57(7):313-6. PubMed ID: 24052442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of trigeminal neuropathic pains.
    Zakrzewska JM
    Expert Opin Pharmacother; 2010 Jun; 11(8):1239-54. PubMed ID: 20426709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.
    Winkler I; Sobol E; Yagen B; Steinman A; Devor M; Bialer M
    Neuropharmacology; 2005 Dec; 49(8):1110-20. PubMed ID: 16055160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the drug treatment of neuropathic pain. Part 2: antiepileptics and other drugs.
    Drug Ther Bull; 2012 Nov; 50(11):126-9. PubMed ID: 23154593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantiomerically pure synthesis of beta-substituted gamma-butyrolactones: a key intermediate to concise synthesis of pregabalin.
    Ok T; Jeon A; Lee J; Lim JH; Hong CS; Lee HS
    J Org Chem; 2007 Sep; 72(19):7390-3. PubMed ID: 17715971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
    Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
    Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.